Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study
Alimentary Pharmacology & Therapeutics2013Vol. 38(7), pp. 741–751
Citations Over TimeTop 1% of 2013 papers
Antonio Tursi, Giovanni Brandimarte, Walter Elisei, Marcello Picchio, Giacomo Forti, G Pianese, Stefano Rodinò, Teresa D'Amico, N. Saccà, Piero Portincasa, Erminio Capezzuto, Roberto Lattanzio, Antonio Spadaccini, Serafina Fiorella, F. Polimeni, N Polimeni, V. Stoppino, G. Stoppino, Gian Marco Giorgetti, Fabio Aiello, Silvio Danese
Abstract
Both cyclic mesalazine and Lactobacillus casei subsp. DG treatments, particularly when given in combination, appear to be better than placebo for maintaining remission of symptomatic uncomplicated diverticular disease. (ClinicalTrials.gov: NCT01534754).
Related Papers
- → Maintenance Treatment of Ulcerative Proctitis With Mesalazine Suppositories: A Double-Blind Placebo-Controlled Trial(1998)66 cited
- → Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double‐blind, randomized, placebo‐controlled study(2000)60 cited
- [Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].(1992)
- → Schizophrenia: Do we really need placebo-controlled studies?(1998)20 cited